<DOC>
	<DOC>NCT00159900</DOC>
	<brief_summary>The study objective is to evaluate the effect that sildenafil citrate has on the hardness of erections in males with erectile dysfunction, based on subject responses to question 5 on the Event Log (hardness of erection) as measured at the end of double blind treatment (week 6).</brief_summary>
	<brief_title>Quality of Erection Study</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Male subjects aged 1855 Documented clinical diagnosis of erectile dysfunction confirmed by an IIEFEF Domain score of less than or equal to 25. (If the subject scores greater than 25 on the IIEFEF Domain, screening procedures should be terminated.) Subjects who have been treated with more than 6 doses of sildenafil citrate or any other phosphodiesterase type 5 (PDE5) inhibitor such as vardenafil or tadalafil for erectile dysfunction [Note: subjects should not have taken any PDE5 inhibitors within 4 weeks prior to the date of screening]</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Impotence</keyword>
</DOC>